Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data

被引：0
|
作者：
L. Cui
T. He
Y. Jiang
M. Li
O. Wang
R. Jiajue
Y. Chi
Q. Xu
X. Xing
W. Xia
机构：
[1] Chinese Academy of Medical Sciences,Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital
[2] Chinese Academy of Medical Sciences,Department of Hematology, Peking Union Medical College Hospital
[3] Beijing Jishuitan Hospital,Department of Orthopedics
来源：
Osteoporosis International | 2020年 / 31卷
关键词：
Chinese; cost-effectiveness; FRAX; Markov; osteoporosis; zoledronate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：307 / 316
页数：9
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS ANALYSIS OF TUMOR TREATING FIELDS IN THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA BASED ON REAL-WORLD DATA
    Xiang, Y.
    Xu, Z.
    Zhou, S.
    Liu, S.
    Chen, Y.
    VALUE IN HEALTH, 2023, 26 (06) : S76 - S76
  • [22] USE OF REAL-WORLD DATA IN COST-EFFECTIVENESS ANALYSIS OF SEQUENTIAL BIOLOGIC TREATMENT FOR RHEUMATOID ARTHRITIS
    Singh, J.
    Stevenson, M. D.
    Hyrich, K.
    Gillies, C.
    Abrams, K.
    Bujkiewicz, S.
    VALUE IN HEALTH, 2022, 25 (12) : S373 - S374
  • [23] Use Of Real-World Data In Cost-effectiveness Analysis Of Sequential Biologic Treatment For Rheumatoid Arthritis
    Singh, Janharpreet
    Stevenson, Matt
    Hyrich, Kimme
    Gillies, Clare
    Abrams, Keith
    Bujkiewicz, Sylwia
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP49 - NP50
  • [24] Cost-effectiveness analysis of fosnetupitant in patients receiving cisplatin in Japan: analysis based on real-world data
    Inano, Hiroshi
    Morimoto, Yoshihito
    Kitagawa, Kanata
    Shibuya, Akito
    Nakagomi, Kozue
    Ota, Tomohiro
    Anzo, Yuri
    Miyauchi, Rika
    Shono, Aiko
    Watanabe, Kazuhiro
    Otori, Katsuya
    SUPPORTIVE CARE IN CANCER, 2025, 33 (02)
  • [25] Cost-effectiveness of Ibandronate injection in the treatment of US women with postmenopausal osteoporosis.
    Earnshaw, Stephanie R.
    Graham, Christopher N.
    Amonkar, Mayur M.
    Barr, Charles E.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S584 - S584
  • [26] COST-EFFECTIVENESS ANALYSES OF SCREENING AND TREATMENT STRATEGIES FOR POSTMENOPAUSAL OSTEOPOROSIS IN CHINESE WOMEN
    Si, L.
    Winzenberg, T. M.
    Wang, L.
    Palmer, A. J.
    VALUE IN HEALTH, 2014, 17 (07) : A773 - A773
  • [27] Real-world cost-effectiveness of pharmacogenetic screening for epilepsy treatment
    Chen, Zhibin
    Liew, Danny
    Kwan, Patrick
    NEUROLOGY, 2016, 86 (12) : 1086 - 1094
  • [28] THE COST-EFFECTIVENESS OF OPIOID AGONIST TREATMENT AMONG OPIOID DEPENDENT INDIVIDUALS: EVIDENCE FROM THE REAL-WORLD DATA
    Chang, Kun Chia
    Lee, Kuan Ying
    Lu, Tsung Hsueh
    Der Wang, Jung
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : I12 - I13
  • [29] Cost-effectiveness analysis of screening for osteoporosis in postmenopausal women with primary biliary cirrhosis
    Talwalkar, JA
    Angulo, P
    Lindor, KD
    GASTROENTEROLOGY, 2002, 123 (01) : 88 - 89
  • [30] An analysis of real-world cost-effectiveness of TAVI in South Africa
    Mabin, Thomas A.
    Candolfi, Pascal
    CARDIOVASCULAR JOURNAL OF AFRICA, 2014, 25 (01) : 21 - 26
12345